These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 16359827)

  • 1. The dialectics of cancer: A theory of the initiation and development of cancer through errors in RNAi.
    Wynter CV
    Med Hypotheses; 2006; 66(3):612-35. PubMed ID: 16359827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
    Teodoridis JM; Strathdee G; Brown R
    Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic changes in solid and hematopoietic tumors.
    Toyota M; Issa JP
    Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
    Clark SJ
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference--significance and applications.
    Stanisławska J; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):39-46. PubMed ID: 15761375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Great potential of small RNAs: RNA interference and microRNA].
    Vázquez-Ortiz G; Piña-Sánchez P; Salcedo M
    Rev Invest Clin; 2006; 58(4):335-49. PubMed ID: 17146945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short interfering RNAs as a tool for cancer gene therapy.
    Izquierdo M
    Cancer Gene Ther; 2005 Mar; 12(3):217-27. PubMed ID: 15550938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A.
    Mook OR; Baas F; de Wissel MB; Fluiter K
    Cancer Gene Ther; 2009 Jun; 16(6):532-8. PubMed ID: 19165236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo DNA methylation induced by siRNA targeted to endogenous transcribed sequences is gene-specific and OsMet1-independent in rice.
    Miki D; Shimamoto K
    Plant J; 2008 Nov; 56(4):539-49. PubMed ID: 18643988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic changes in cancer.
    Grønbaek K; Hother C; Jones PA
    APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.
    Niu J; Xu Z; Li XN; Han Z
    Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins.
    Lopez-Serra L; Ballestar E; Ropero S; Setien F; Billard LM; Fraga MF; Lopez-Nieva P; Alaminos M; Guerrero D; Dante R; Esteller M
    Oncogene; 2008 Jun; 27(25):3556-66. PubMed ID: 18223687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAi-mediated pathways in the nucleus.
    Matzke MA; Birchler JA
    Nat Rev Genet; 2005 Jan; 6(1):24-35. PubMed ID: 15630419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional gene silencing by short interfering RNAs.
    Kawasaki H; Taira K
    Curr Opin Mol Ther; 2005 Apr; 7(2):125-31. PubMed ID: 15844619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant gene silencing in tumor progression: implications for control of cancer.
    Baylin SB; Chen WY
    Cold Spring Harb Symp Quant Biol; 2005; 70():427-33. PubMed ID: 16869780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic changes in cancer and preneoplasia.
    Herman JG
    Cold Spring Harb Symp Quant Biol; 2005; 70():329-33. PubMed ID: 16869769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-interference-directed chromatin modification coupled to RNA polymerase II transcription.
    Schramke V; Sheedy DM; Denli AM; Bonila C; Ekwall K; Hannon GJ; Allshire RC
    Nature; 2005 Jun; 435(7046):1275-9. PubMed ID: 15965464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular therapy in the microRNA era.
    Wurdinger T; Costa FF
    Pharmacogenomics J; 2007 Oct; 7(5):297-304. PubMed ID: 17189960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.